Prostate Cancer Clinical Decision Making by Diagnosed and High Risk Latino Men

确诊和高危拉丁裔男性的前列腺癌临床决策

基本信息

批准号：
7531018
负责人：
SALLY L Maliski
金额：
$ 19.25万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-09-26 至 2010-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7531018
关键词：
Accounting Acculturation Address Attention Attitude Belief Brothers California Caucasians Caucasoid Race Cause of Death Clinical Consensus Country Data Decision Making Depth Development Diagnosis Disadvantaged Disclosure Disease Early treatment Education Face Feeling First Degree Relative Foundations Future Healthcare Hispanics Immigrant Individual Intervention Interview Knowledge Language Latino Life Literature Low income Malignant neoplasm of prostate Medical Methods Mexican Mexican Americans Minority Modeling Perception Population Process Public Health Purpose Rate Reporting Research Review Literature Risk Role Screening for Prostate Cancer Screening procedure Second Primary Cancers Son Source Staging Treatment outcome Uncertainty Uninsured United States Variant Writing base cancer therapy coping experience high risk men men men&apos s group mortality social disparities

项目摘要

DESCRIPTION (provided by applicant): Prostate cancer is the most common noncutaneous cancer and second leading cause of death among men in the United States, and Latinos are the fastest growing minority in the United States. However, low income Latino men are more likely to be uninsured, have less education, and have lower incomes. Many do not speak English as their first language. For these men, much of the available information to help with informed decision-making is not accessible. Because of the lack of consensus on the benefits of screening on prostate cancer mortality or of superior survival benefit of any one treatment for early stage prostate cancer, men are faced with life-altering decisions regarding screening and treatment for those who are diagnosed. Furthermore, men with a first degree relative with prostate cancer are at increased risk. Yet, how the rapidly growing population of Latino men approaches the decision-making process in prostate cancer is virtually unknown. Therefore, the overall purpose of this study is to develop descriptive models of prostate cancer screening, treatment, and diagnosis disclosure decision-making from the perspective of Latino men to form an evidence base for the development of culturally appropriate intervention strategies to facilitate informed and confident decision-making. Specifically, we aim to: 1. Describe the process of deciding on treatment and disclosing diagnosis from the perspective of Latino men who have been treated for prostate cancer and 2. Describe the process of deciding to be screened or not screened for prostate cancer by brothers or sons of Latino men diagnosed with prostate cancer. We will use qualitative descriptive methods to understand prostate cancer treatment, disclosure, and screening decision-making processes from the perspective of Latino men. Both specific aims will be addressed with in-depth individual interviews exploring involvement in and comfort with treatment decision making process, influences on the decision, and disclosure of diagnosis by treated men. For high risk men we will explore risk perception, knowledge and beliefs about prostate cancer screening, sources of information, facilitators and barriers, and decision implementation. Analyses will result in clear, in-depth descriptions that will guide the future development of intervention strategies to facilitate informed decision-making regarding prostate cancer treatment, disclosure, and screening among Latino men facing prostate cancer decisions. PUBLIC HEALTH RELEVANCE: The relevance of this study to public health lies in the fact that Latinos are the fastest growing minority in the United States and Mexican/Mexican-Americans make up over 70% of this growing Latino population. Understanding how treatment, disclosure, and screening decisions are made by Mexican/Mexican-American men from this research will lay the foundation for culturally relevant interventions to assist these men as they face life-altering decisions. Potentially, informed, confident decision-making participation may contribute to better treatment outcomes and appropriate screening for this disadvantaged group of men.

描述（由申请人提供）：前列腺癌是美国男性中最常见的非皮肤癌，也是第二大死因，拉丁裔是美国增长最快的少数族裔。然而，低收入拉丁裔男性更有可能没有保险、受教育程度较低且收入较低。许多人的母语不是英语。对于这些人来说，许多有助于做出明智决策的可用信息是无法获得的。由于对于筛查对前列腺癌死亡率的益处或任何一种早期前列腺癌治疗的优越生存益处缺乏共识，男性在筛查和治疗确诊患者方面面临着改变生活的决定。此外，一级亲属患有前列腺癌的男性风险更高。然而，快速增长的拉丁裔男性群体如何处理前列腺癌的决策过程实际上是一个难题。未知。因此，本研究的总体目的是从拉丁裔男性的角度开发前列腺癌筛查、治疗和诊断披露决策的描述性模型，为制定文化上适当的干预策略提供证据基础，以促进知情和自信决策。具体来说，我们的目标是： 1. 从接受过前列腺癌治疗的拉丁裔男性的角度描述决定治疗和披露诊断的过程，以及 2. 描述兄弟决定接受或不接受前列腺癌筛查的过程或被诊断患有前列腺癌的拉丁裔男性的儿子。我们将使用定性描述方法从拉丁裔男性的角度来了解前列腺癌的治疗、披露和筛查决策过程。这两个具体目标都将通过深入的个人访谈来解决，探讨治疗决策的参与度和舒适度过程、对决策的影响以及接受治疗的男性诊断的披露。对于高风险男性，我们将探讨有关前列腺癌筛查的风险认知、知识和信念、信息来源、促进因素和障碍以及决策实施。分析将产生清晰、深入的描述，指导干预策略的未来发展，以促进面临前列腺癌决策的拉丁裔男性在前列腺癌治疗、披露和筛查方面做出明智的决策。公共卫生相关性：本研究与公共卫生的相关性在于，拉丁裔是美国增长最快的少数族裔，而墨西哥/墨西哥裔美国人占这一不断增长的拉丁裔人口的 70% 以上。通过这项研究了解墨西哥/墨西哥裔美国男性如何做出治疗、披露和筛查决定，将为文化相关干预措施奠定基础，以帮助这些男性面临改变生活的决定。知情、自信的决策参与可能有助于为这一弱势男性群体提供更好的治疗结果和适当的筛查。